Safety and efficacy of the addition of pertuzumab to T-DM1 ± taxane in patients with HER2-positive, locally advanced or metastatic breast cancer: a pooled analysis

BACKGROUND: The aim of this review was to systematically evaluate the safety and efficacy of the addition of pertuzumab to trastuzumab emtansine (T-DM1) ± taxane in patients with human epidermal growth factor receptor 2 (HER2)-positive, locally advanced breast cancer (LABC) or metastatic breast canc...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jing, Li, Jinying, Zhu, Chenjing, Song, Yanlin, Xia, Fan, Ma, Xuelei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5695268/
https://www.ncbi.nlm.nih.gov/pubmed/29180848
http://dx.doi.org/10.2147/DDDT.S149032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5695268/
https://www.ncbi.nlm.nih.gov/pubmed/29180848
http://dx.doi.org/10.2147/DDDT.S149032

Ejemplares similares